- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Mettler-Toledo International Inc(MTD)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for MTD
11/13/2026: MTD (2-star) has a low Upturn Star Rating. Not recommended to BUY.
Mettler-Toledo International Inc is a prominent global provider of precision instruments for laboratory, industrial, and food safety sectors. The company is distinguished by its high-quality, high-margin business model, which generates significant recurring revenue through essential services and consumables. Its primary growth story involves capitalizing on increasing regulatory demands for quality and safety, alongside technological advancements in connected lab systems. Key risks include a high valuation, which leaves little margin for error, and cyclical exposure to industrial and research capital budgets. The stock is typically best suited for long-term growth investors who value operational discipline over dividend income, and it is a stock to monitor for industrial spending trends.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | The company has a track record of consistent earnings growth and market leadership in its niche segments. |
| Momentum investor | Mixed fit | Momentum appeal depends on current market sentiment regarding capital expenditure cycles; monitor for upturn signals. |
| Value investor | Weak fit | MTD typically trades at a premium valuation reflecting its high quality and stable margins. |
| Dividend investor | Weak fit | The company does not pay a cash dividend, opting to return capital through share repurchases instead. |
| Low-risk investor | Mixed fit | While the business quality is high, the stock's valuation and volatility can be higher than traditional 'safe' defensive stocks. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium / high | The stock often reacts significantly to changes in global industrial production forecasts. |
| Valuation risk | High | As a high-quality compounder, the stock frequently trades at a high P/E multiple that requires sustained growth to justify. |
| Competition risk | Medium | Continuous pressure from peers like Thermo Fisher and Sartorius requires constant innovation in lab technologies. |
| Business quality | Strong | The high recurring revenue from services creates a durable, defensive moat around its core business. |
| Dividend income | Low / none | Investors looking for immediate income will not find a cash dividend yield here. |
| Execution risk | Medium | Success relies heavily on integrating acquisitions effectively and maintaining global operational efficiency. |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 34.59B USD | Price to earnings Ratio 37.74 | 1Y Target Price 1737.5 |
Price to earnings Ratio 37.74 | 1Y Target Price 1737.5 | ||
Volume (30-day avg) 198.3K shares | Beta 1.17 | 52 Weeks Range 1023.05 - 1806.58 | Updated Date 11/14/2026 |
52 Weeks Range 1023.05 - 1806.58 | Updated Date 11/14/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 46.07 |
Sector & Industry Intelligence
Sector
Healthcare
Bullish- Sentiment
- Strong Bullish
- Momentum
- Momentum Steady
- BUY participation
- 62.6%
- Active BUY / eligible
- 72 / 115
- 30-Day BUY Count Change
- +35
- Market state
- Strong Bullish
The number of qualifying BUY stocks has remained relatively stable.
Industry
Diagnostics & Research
- BUY participation
- 68.8%
- Active BUY / eligible
- 11 / 16
- 30-Day BUY Count Change
- 0
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.

Moderately Choppy
The stock has experienced noticeable price swings while retaining some directional structure.
Analysis of Past Performance
Type Stock | Historic Profit 2.78% | Avg. Invested days 49 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Laboratory Instrumentation | Analytical balances, pipettes, and automated lab systems for life science research. | This is a stable, high-margin foundation that relies on scientists and researchers needing reliable data. |
| Industrial/Product Inspection | Checkweighing, metal detection, and X-ray systems for food and drug safety. | This segment is driven by global health regulations which force manufacturers to buy MTD's safety equipment. |
| Service and Support | Maintenance contracts, calibration, and spare parts for the installed base. | These are recurring fees that provide predictable cash flow regardless of new product sales. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2026-11-05 | When After Market | Estimate 12.11 | Actual 12.57 |
Profitability
Profit Margin 22.25% | Operating Margin (TTM) 27.82% |
Management Effectiveness
Return on Assets (TTM) 20.23% | Return on Equity (TTM) 29.51% |
Valuation
Trailing PE 37.74 | Forward PE 33.22 | Enterprise Value 36.56B | Price to Sales(TTM) 8.24 |
Enterprise Value 36.56B | Price to Sales(TTM) 8.24 | ||
Enterprise Value to Revenue 8.71 | Enterprise Value to EBITDA 27.56 | Shares Outstanding 19.89M | Shares Floating 19.78M |
Shares Outstanding 19.89M | Shares Floating 19.78M | ||
Percent Insiders 1.17 | Percent Institutions 104.21 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

